Figitumumab

DB11685InvestigationalProtein Based Therapies

Figitumumab has been used in trials studying the treatment of Sarcoma, Solid Tumor, Breast Cancer, Lung Neoplasms, and Advanced Cancer, among others.

Mechanism: Pharmacologically active on Insulin-like growth factor 1 receptor
Curator reviewed
Code names: CP-751,871

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

14Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Figitumumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.